Arkolith/Insider Trading/BIIB/Form 4

Murphy Nicole

Head of Pharm Ops and TechBIOGEN INC. (BIIB) · full profile →Form 4 · filed Feb 10, 2026
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
9
6 non-derivative · 3 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Feb 6, 2026Tax withholding(F)1K$201.18$283K20K
Feb 6, 2026Tax withholding(F)914$201.18$184K16K
Feb 6, 2026Option exercise(M)2K—$017K
Feb 6, 2026Tax withholding(F)1K$201.18$205K15K
Feb 6, 2026Option exercise(M)2K—$016K
Feb 6, 2026Option exercise(M)5K—$021K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Feb 6, 2026Option exercise(M)2K—$00
Feb 6, 2026Option exercise(M)2K—$02K
Feb 6, 2026Option exercise(M)5K—$09K

Transaction Codes

F
Shares withheld for taxes
M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000875045-26-000022) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML

Keep exploring

Connected pages for BIOGEN INC.

Build

Ask your agent about BIIB insider filings

This filing is the Follow view. The Build view lets your agent pull every Form 4 for the issuer, the net open-market picture over 90 days, and the accession behind each row, through REST or MCP.

Get a key Compare plansForm 4 data
Copy-paste
curl -H "Authorization: Bearer YOUR_API_KEY" \
  "https://arkolith.com/api/v1/filing/0000875045-26-000022"
Ask your agent
Use Arkolith to summarize insider buying and selling at BIOGEN INC.
over the last 90 days and cite the filings.